Neumora Therapeutics, Inc 10-K for FY2023
Neumora Therapeutics, Inc. (NMRA)
10-K
2024-03-07
For: 2023-12-31
View Original
Added on
April 06, 2026
About this 10-K
Neumora Therapeutics, Inc filed this 10-K on March 7, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $235.93M
- compared with a net loss of $130.9M a year earlier
- Diluted EPS
- -$3.63
- compared with -$4.81 a year earlier